Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Topical therapy in pregnancy].

A Zesch1

  • 1Institut für Arzneimittel des Bundesgesundheitsamtes Berlin.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cosmetics: definition and legal aspects of the term].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·1999
Same author

[Therapy of psoriasis with fumaderm preparation].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·1995
Same author

Decontamination of human skin exposed to 2,3,7,8-tetrachlorodibenzo-p-Dioxin (TCDD) in vitro.

Archives of environmental health·1992
Same author

Penetration, distribution and kinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human skin in vitro.

Archives of toxicology·1991
Same author

[Local treatment with corticosteroids--limits on the duration of administration].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·1990
Same author

[Aspects of tolerance to transdermal systems from the dermatologic viewpoint].

Arzneimittel-Forschung·1989
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Drug administration during pregnancy requires careful risk-benefit assessment. Some topical medications may pose risks to fetal development, necessitating caution and specific application periods.

Area of Science:

  • Pharmacology
  • Toxicology
  • Obstetrics

Context:

  • Drug administration during pregnancy necessitates careful benefit-risk evaluation.
  • Topical therapies, while generally considered safe, may involve active substances with unknown or relevant embryotoxic potential.
  • Existing data on the safety of many topical agents during pregnancy is limited.

Purpose:

  • To review active substances used in topical therapies during pregnancy.
  • To identify topical medications that should be avoided or used with caution during pregnancy.
  • To highlight the uncertainties and lack of data regarding the safety of certain topical agents.

Summary:

  • This review discusses topical medications applied during pregnancy.
  • Several active substances used in local therapy present potential risks to fetal development.

Related Experiment Videos

  • Recommendations are provided for the use of specific topical agents, with emphasis on periods of application and areas where data is lacking.

    • Impact:

    • Provides guidance for healthcare providers on the safe use of topical medications in pregnant patients.
    • Highlights the need for further research into the safety profiles of topical agents during gestation.
    • Contributes to informed decision-making regarding drug administration in pregnancy to minimize potential harm.